News
Results of a retrospective study demonstrated that retreatment with ICIs after severe immune-related adverse events could result in good response for select patients.
Decision-making was influenced by patient values and did not vary by stage, race and ethnicity, or demographics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results